Drew Micciche, MD, an assistant professor of emergency medicine and an attending physician on UK’s Addiction Consult and Education Services, has been selected as UK’s Bell Addiction Medicine Scholar for 2024-2025.
The mission of the Bell Alcohol and Addiction Endowed Chair is to build a broader base of physician education and training experiences in treating patients with substance use disorders at UK HealthCare.
Dr. Micciche’s focus during his year as the Bell Addiction Medicine Scholar will be multifaceted, addressing several key areas in addiction medicine. He plans to work with staff and providers to increase the initiation of buprenorphine within the emergency department, ensure its appropriate continuation for admitted patients, implement new workflows for providing fentanyl test strips to at-risk patients, and enhance the quality of outpatient resources provided to patients with substance use disorder upon discharge from the emergency department.
Dr. Micciche is a toxicology and hyperbaric medicine consultant and works for the Kentucky Poison Control Center. He also regularly teaches and mentors residents and medical students at various levels of training. His primary clinical interests include diagnosing and managing poisoned and envenomated patients and treating patients with substance use disorders.
After earning his MD from the UK College of Medicine, Dr. Micciche pursued residency training in emergency medicine at the University of Pittsburgh Medical Center and completed a fellowship in medical toxicology at the same institution.
After completing his training, Micciche returned to Lexington to join the clinical faculty at UK. His diverse roles within the college and UK HealthCare underscore his commitment to advancing patient care and medical education in emergency medicine and addiction treatment.
This story originally appeared in UKNow on Aug. 19, 2024.